发明名称 Targeted Modified IL-1 Family Members
摘要 The present disclosure relates to a modified Interleukin-1 (IL-1) family member cytokine, with reduced activity via its cytokine receptor, wherein said interleukin-1 family member cytokine is specifically delivered to target cells. Preferably, the IL-1 family member cytokine is a mutant, more preferably it is a mutant IL-1 with low affinity to the IL-1 receptor, wherein said mutant IL-1 is specifically delivered to target cells. The targeting is preferably realized by fusion of the modified IL-1 family member cytokine to a targeting moiety, preferably an antibody or antibody-like molecule. The disclosure relates further to the use of such targeted modified IL-1 family member cytokine to treat diseases.
申请公布号 US2016152730(A1) 申请公布日期 2016.06.02
申请号 US201414905352 申请日期 2014.07.04
申请人 VIB VZW ;UNIVERSITEIT GENT ;CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE ;UNIVERSTITÉ MONTPELLIER 2 ;CENTRE HOSPITALIER REGIONAL UNIVERSITAIRE DE MONTPELLIER 发明人 Tavernier Jan;Gerlo Sarah;Peelman Frank;Uze Gilles
分类号 C07K16/40;C07K14/545 主分类号 C07K16/40
代理机构 代理人
主权项 1. A targeting construct, comprising a modified IL-1 family cytokine characterized by a reduced affinity for its receptor, and a targeting moiety.
地址 Gent BE